Apex Wellness Medipharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-01-2025
- Paid Up Capital ₹ 0.10 M
as on 16-01-2025
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -12.96%
(FY 2023)
- Profit -12.25%
(FY 2023)
- Ebitda -3.68%
(FY 2023)
- Net Worth 2.01%
(FY 2023)
- Total Assets 3.11%
(FY 2023)
About Apex Wellness Medipharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Apex Wellness Medipharma Private Limited India is Indranil Roychoudhury as CEO. Rupen Kothari, Sheetal Kothari, Viswanath Billa, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191MH2012PTC227765
- Company No.
227765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2012
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Apex Wellness Medipharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indranil Roychoudhury | CEO | 16-May-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaishali Bichu  | Director | 29-Jan-2014 | Current |
| Rupen Kothari | Director | 06-Mar-2012 | Current |
| Sheetal Kothari | Director | 06-Mar-2012 | Current |
| Viswanath Billa | Director | 29-Jan-2014 | Current |
Financial Performance of Apex Wellness Medipharma.
Apex Wellness Medipharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.96% decrease. The company also saw a substantial fall in profitability, with a 12.25% decrease in profit. The company's net worth moved up by a moderate rise of 2.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Wellness Medipharma?
In 2023, Apex Wellness Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kidney Care Lab Private LimitedActive 12 years 10 monthsSheetal Kothari, Viswanath Billa and 2 more are mutual person
Apex Kidney Care Private LimitedActive 17 years 6 monthsRupen Kothari, Sheetal Kothari and 2 more are mutual person
Apex Dialysis Technologies Private LimitedActive 13 years 3 monthsRupen Kothari, Sheetal Kothari and 3 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apex Wellness Medipharma?
Apex Wellness Medipharma has a workforce of 7 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Wellness Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Wellness Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
